Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products.
DISEASE OVERVIEW
Klebsiella pneumoniae belongs to the class of Gram-negative bacteria, primarily spread from person-to-person contact or environment but not through air. In normal conditions, Klebsiella Pneumoniae lives in intestines and is not dangerous in healthy individuals. However, based on the route of entry of the bacteria, different infections such as pneumonia, blood/ wound-infections, meningitis etc. occur.
As some of the bacteria are highly resistant to antibiotics, infections caused by the bacteria are difficult for treatment. Accordingly, 25+ companies are investing their resources in development of Klebsiella pneumonia infection treatment pipeline compounds.
Companies currently investing in Klebsiella Pneumoniae pipeline development include- ABAC Therapeutics SA, Abgentis Limited, AmpliPhi Biosciences Corporation, Appili Therapeutics Inc, Arsanis Inc, C3J Therapeutics Inc, ContraFect Corporation, Debiopharm International SA, EnBiotix Inc, Evaxion Biotech ApS, Fedora Pharmaceuticals Inc, Forge Therapeutics Inc, Innovation Pharmaceuticals Inc, LegoChem Biosciences Inc, Melinta Therapeutics Inc, Nosopharm SAS, Oryn Therapeutics LLC, Phico Therapeutics Ltd, Shionogi & Co Ltd, Spero Therapeutics Inc, Syntiron LLC, Tetraphase Pharmaceuticals Inc, Vaxdyn SL and Vaxxilon AG.
REPORT DESCRIPTION
The Klebsiella pneumoniae pipeline guide presents complete overview of drugs currently being developed for Klebsiella pneumoniae. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).
Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Klebsiella pneumoniae pipeline candidate.
Research and Development progress along with latest news related to each of the Klebsiella pneumoniae pipeline candidates is included.
Major companies participating in therapeutic development of Klebsiella pneumoniae are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.
Amid strong interest for cure of Klebsiella pneumoniae from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Klebsiella pneumoniae clinical and pre-clinical products.
The report assists in identifying potential upcoming companies and drugs in Klebsiella pneumoniae pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.
Scope of Klebsiella pneumoniae pipeline report includes
- Panorama of Klebsiella pneumoniae pipeline markets including statistics on therapeutic drugs and companies involved
- Klebsiella pneumoniae Pipeline candidates across various development phases including both pre-clinical, discovery and clinical stages are covered
- Klebsiella pneumoniae pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study
- Overview of companies participating in Klebsiella pneumoniae pipeline with short introduction to their businesses and pipeline projects
- For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co-developer and licensee are provided.
- Research and Development progress and trial details, results wherever available, are also included in the pipeline study
- The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Klebsiella pneumoniae pipeline therapeutics
Reasons to Buy
- Get clear understanding of the entire Klebsiella pneumoniae pipeline, with details on active projects
- Get in detail information of each product with updated information on each project along with key milestones
- Know the list of companies participating in global Klebsiella pneumoniae pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
- Get trial information for each pipeline product under development
- Understand the pipeline structure in terms of mechanism of Action, phase and company